DIA 2023: PALADIN Brings Patient Advocacy and Industry Together

Published on: 

New pre-competitive, disease-agnostic Consortium hopes to optimize advocacy group-industry collaboration to ultimately accelerate the pace of medicines development.

In this interview, Vicky DiBiaso, Global Head, Patient Informed Development & Health Value Translation at Sanofi and Kenneth Getz, Executive Director/Professor, Tufts CSDD and Founder/Board Chair, CISCRP, discuss the formation, mission and goals for the newly-launched Patient Advocacy Leaders And Drug (Development) Industry Network or PALADIN.

Read more on PALADIN's formation.

Advertisement